Bender, D., Sill, M. W., Lankes, H. A., Reyes, H. D., Darus, C. J., Delmore, J. E., . . . Leslie, K. K. (2015). A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol.
Citação norma ChicagoBender, David, et al. "A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2015.
Citação norma MLABender, David, et al. "A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.